Thies F, Miles E A, Nebe-von-Caron G, Powell J R, Hurst T L, Newsholme E A, Calder P C
Department of Biochemistry, University of Oxford, United Kingdom.
Lipids. 2001 Nov;36(11):1183-93. doi: 10.1007/s11745-001-0831-4.
Greatly increasing the amounts of flaxseed oil [rich in alpha-linolenic acid (ALNA)] or fish oil (FO); [rich in eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)] in the diet can decrease inflammatory cell functions and so might impair host defense. The objective of this study was to determine the effect of dietary supplementation with moderate levels of ALNA, gamma-linolenic acid (GLA), arachidonic acid (ARA), DHA, or FO on inflammatory cell numbers and functions and on circulating levels of soluble adhesion molecules. Healthy subjects aged 55 to 75 yr consumed nine capsules per day for 12 wk. The capsules contained placebo oil (an 80:20 mix of palm and sunflowerseed oils) or blends of placebo oil with oils rich in ALNA, GLA, ARA, or DHA or FO. Subjects in these groups consumed 2 g ALNA; approximately 700 mg GLA, ARA, or DHA; or 1 g EPA plus DHA (720 mg EPA + 280 mg DHA) daily from the capsules. Total fat intake from the capsules was 4 g per day. None of the treatments affected inflammatory cell numbers in the bloodstream; neutrophil and monocyte phagocytosis or respiratory burst in response to E. coli; production of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-6 in response to bacterial lipopolysaccharide; or plasma concentrations of soluble intercellular adhesion molecule-1. In contrast, the ALNA and FO treatments decreased the plasma concentrations of soluble vascular cell adhesion molecule-1 (16 and 28% decrease, respectively) and soluble E-selectin (23 and 17% decrease, respectively). It is concluded that, in contrast to previous reports using higher amounts of these fatty acids, a moderate increase in consumption of long-chain n-6 or n-3 polyunsaturated fatty acids does not significantly affect inflammatory cell numbers or neutrophil and monocyte responses in humans and so would not be expected to cause immune impairment. Furthermore, we conclude that moderate levels of ALNA and FO, which could be incorporated into the diet, can decrease some markers of endothelial activation and that this mechanism of action may contribute to the reported health benefits of n-3 fatty acids.
大幅增加饮食中富含α-亚麻酸(ALNA)的亚麻籽油或富含二十碳五烯酸(EPA)和二十二碳六烯酸(DHA)的鱼油的摄入量,可能会降低炎症细胞功能,进而损害宿主防御能力。本研究的目的是确定饮食中补充适量的ALNA、γ-亚麻酸(GLA)、花生四烯酸(ARA)、DHA或鱼油对炎症细胞数量和功能以及可溶性黏附分子循环水平的影响。55至75岁的健康受试者每天服用9粒胶囊,持续12周。胶囊中含有安慰剂油(棕榈油和向日葵籽油80:20的混合物)或安慰剂油与富含ALNA、GLA、ARA或DHA或鱼油的油的混合物。这些组中的受试者每天从胶囊中摄入2克ALNA;约700毫克GLA、ARA或DHA;或1克EPA加DHA(720毫克EPA + 280毫克DHA)。胶囊中的总脂肪摄入量为每天4克。没有一种处理影响血液中的炎症细胞数量;对大肠杆菌的中性粒细胞和单核细胞吞噬作用或呼吸爆发;对细菌脂多糖的肿瘤坏死因子-α、白细胞介素-1β和白细胞介素-6的产生;或可溶性细胞间黏附分子-1的血浆浓度。相比之下,ALNA和鱼油处理降低了可溶性血管细胞黏附分子-1的血浆浓度(分别降低16%和28%)和可溶性E-选择素(分别降低23%和17%)。结论是,与之前使用较高量这些脂肪酸的报告相反,适度增加长链n-6或n-3多不饱和脂肪酸的摄入量不会显著影响人类的炎症细胞数量或中性粒细胞和单核细胞反应,因此预计不会导致免疫损害。此外,我们得出结论,可纳入饮食中的适量ALNA和鱼油可以降低一些内皮细胞活化的标志物,并且这种作用机制可能有助于n-3脂肪酸所报告的健康益处。